Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study

Overviews of biological importance of quercetin: A bioactive flavonoid

Parasuraman, S., David, A. A., & Arulmoli, R. (2016) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.194044 · Cited by 1,619

Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application

Xu, D. W., Hu, M.-J., Wang, Y.-Q., & Cui, Y. (2019) · Molecules · doi:10.3390/molecules24061123 · Cited by 1,306

The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review

Wang, W., Sun, C., Mao, L., Ma, P., Liu, F., Yang, J., & Gao, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.07.004 · Cited by 802

The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin

Batiha, G. E., Beshbishy, A. M., Ikram, M., Mulla, Z. S., El-Hack, M. E. A., Taha, A. E.-S., Algammal, A. M., & Elewa, Y. H. A. (2020) · Foods · doi:10.3390/foods9030374 · Cited by 716

Candidate drugs against SARS-CoV-2 and COVID-19

McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104859 · Cited by 572

Therapeutic potential of quercetin as a cardiovascular agent

Patel, R. V., Mistry, B. M., Shinde, S. K., Syed, R., Singh, V., & Shin, H. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.06.053 · Cited by 506

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Zhang, D., Wu, K.-L., Zhang, X., Deng, S.-Q., & Peng, B. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.02.005 · Cited by 486

Five reasons why COVID herd immunity is probably impossible

Aschwanden, C. (2021) · Nature · doi:10.1038/d41586-021-00728-2 · Cited by 351

A role for quercetin in coronavirus disease 2019 (COVID‐19)

Derosa, G., Maffioli, P., D’Angelo, A., & Pierro, F. D. (2020) · Phytotherapy Research · doi:10.1002/ptr.6887 · Cited by 307

Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin

Riva, A., Ronchi, M., Petrangolini, G., Bosisio, S., & Allegrini, P. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0517-3 · Cited by 291

Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications

Bowen, D., Pathak, S., Nadar, R. M., Parise, R., Ramesh, S., Govindarajulu, M., Moore, A., Ren, J. T., Moore, T. M., & Dhanasekaran, M. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023085 · Cited by 9

Targeting infections and inflammation through micro and nano-nutraceuticals

Santos, F. H., Panda, S. K., Ferreira, D. C. M., Dey, G., Molina, G., & Pelissari, F. M. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101891 · Cited by 8

COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals

Gonçalves, B. D. S., Sangani, D., Nayyar, A., Puri, R., Irtiza, M., Nayyar, A., Khalyfa, A., Sodhi, K., & Pillai, S. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158481 · Cited by 7

Polyphenolic phytosomes for targeted drug delivery

Khabarov, I. A., Sergazy, S., Аманжан, А., Maikenova, A., Zhabayeva, A. N., & Adekenov, S. M. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106920 · Cited by 9

Targeting SIRT1: A Potential Strategy for Combating Severe COVID‐19

Afra, H. S., Jeyvan, F. S., Barartabar, Z., Khanicheragh, P., Abdolmaleki, E. Y., Ilbeigi, D., Musavi, H., & Malekzadegan, Y. (2025) · BioMed Research International · doi:10.1155/bmri/9507417 · Cited by 7

Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies

Saquib, Q., Bakheit, A. H. H., Ahmed, S., Ansari, S. M., Al-Salem, A. M., & Al-Khedhairy, A. A. (2024) · Molecules · doi:10.3390/molecules29050998 · Cited by 7

Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches

Kandagalla, S., Rimac, H., Gurushankar, K., Novak, J., Grishina, M., & Potemkin, V. (2022) · PeerJ · doi:10.7717/peerj.13374 · Cited by 7

SARS-CoV-2-induced host metabolic reprogram (HMR): nutritional interventions for global management of COVID-19 and post-acute sequelae of COVID-19 (PASC)

Naidu, A. S., Shahidi, F., Wang, C., Sato, K., Wirakartakusumah, A., Aworh, O. C., & Clemens, R. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.18306 · Cited by 7

Novel designed analogues of quercetin against SARS-CoV2:an in-silico pharmacokinetic evaluation, molecular modeling, MD simulations based study

Shamim, S., Akhtar, M., & Gul, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2265469 · Cited by 6

Investigation of potential effects of quercetin on COVID-19 treatment: a systematic review of randomized controlled trials

Beşler, Z. N., Bayraktar, D. Z., Koçak, M. C., & Kızıltan, G. (2024) · Clinical Science of Nutrition · doi:10.62210/clinscinutr.2024.86 · Cited by 7

An Exploratory Review of Potential Adjunct Therapies for the Treatment of Coronavirus Infections

Martin, B. R., & Richardson, J. (2021) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2021.12.005 · Cited by 6

Respiratory viral infections in the elderly: From the perspective of the aging immune system

Zhang, X., Xu, J., Wang, Y., Li, H., Yu, J., Shang, L., Shang, L., Hou, B., Zhang, X., & Cao, B. (2023) · The Innovation Medicine · doi:10.59717/j.xinn-med.2023.100022 · Cited by 5

Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy

Vajdi, M., Karimi, A., Hassanizadeh, S., Farhangi, M. A., Bagherniya, M., Askari, G., Roufogalis, B. D., Davies, N. M., & Sahebkar, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00585-6 · Cited by 6

Sicilian Populations of Capparis spinosa L. and Capparis orientalis Duhamel as Source of the Bioactive Flavonol Quercetin

Sgadari, F., Cerulli, A., Schicchi, R., Badalamenti, N., Bruno, M., & Piacente, S. (2023) · Plants · doi:10.3390/plants12010197 · Cited by 6

Goutweed (Aegopodium podagraria L.)—An Edible Weed with Health-Promoting Properties

Dębia, K., Dzięcioł, M., Wróblewska, A., & Janda, K. (2025) · Molecules · doi:10.3390/molecules30071603 · Cited by 5

A Probable Anti-COVID Phytochemical (1,7-Bis-(4-hydroxyphenyl)-1-heptene-3,5-dione) Screened Computationally from the Rhizome of Curcuma longa

Ezeorba, T. P. C., Uchendu, N. O., Nweze, E. J., Okoroafor, C. K., Ogbu, P. O., Okpara, M. C., Asomadu, R. O., & Joshua, P. E. (2021) · doi:10.3390/ecms2021-10845 · Cited by 5

The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review

Alipour, Z., Zarezadeh, S., & Ghotbi‐Ravandi, A. A. (2023) · Planta Medica · doi:10.1055/a-2209-6357 · Cited by 6

Achyrocline satureioides as an adjuvant therapy for the management of mild viral respiratory infections in the context of COVID ‐19: Preliminary results of a randomized, placebo‐controlled, and open‐label clinical trial

Bastos, C. I. M., Dani, C., Cechinel, L. R., Neves, A. H. D. S., Rasia, F. B., Bianchi, S. E., Loss, E. D. S., Lamers, M. L., Meirelles, G. D. C., Bassani, V. L., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7976 · Cited by 5

Polyphenols-mediated immune regulation: Metabolite-driven epigenetic regulatory mechanisms

Ouyang, B., Wu, Q., Liang, J., Cao, H., & Xiao, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157535 · Cited by 6

Quercetin derivatives in roasted Coffea arabica and its popular beverages

Santanatoglia, A., Navarini, L., Angeloni, S., & Caprioli, G. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.143035 · Cited by 4

Early use of polyphenol-rich Cistus creticus extract containing nasopharyngeal spray is associated with significantly shorter duration of symptoms in mild COVID-19 patients: A retrospective case-control study

(2021) · Journal of Community Medicine and Public Health Reports · doi:10.38207/jcmphr/2021/0208155 · Cited by 4

Integrating network pharmacology and molecular docking to explore the potential mechanism of Xinguan No. 3 in the treatment of COVID-19

Peng, J., Zhang, K., Wang, L., Fang, P., Zhang, C., Long, K., Chen, J. S., Zhou, X., Gao, P., & Fan, G. (2022) · Open Chemistry · doi:10.1515/chem-2022-0178 · Cited by 5

The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure?

Fazio, S., Cosentino, M., Marino, F., Pandolfi, S., Zanolin, E., & Bellavite, P. (2022) · Journal of Pharmacy and Pharmacology Research · doi:10.26502/fjppr.055 · Cited by 5

Application of LC-MS/MS with ion mobility for chemical analysis of propolis extracts with antimicrobial potential

Sofrenić, I. V., Ljujić, J., Simić, K., Ivanović, S., Jeremić, J. S., Ćirić, A., Sokóvić, M., & Andjelković, B. (2021) · Journal of the Serbian Chemical Society · doi:10.2298/jsc210812086s · Cited by 4

"Unimportant" Molecules?-Part 1.

Pizzorno, J. E. (2021) · PubMed Central · Cited by 3

SARS-CoV-2-induced senescence as a potential therapeutic target

Denholm, M., Rintoul, R. C., & Muñoz‐Espín, D. (2022) · European Respiratory Journal · doi:10.1183/13993003.01101-2022 · Cited by 4

Integrative review of flavonoid phytosomes and their potential role in the treatment of SARS-CoV-2 infection (COVID-19), diabetes, and cancer

Hernández-Rosas, N. A., Rivera-Yañez, C. R., Hernández-Sánchez, K. M., Nieto-Yáñez, Ó., Ortega, C. C. B., Gutiérrez‐Rebolledo, G. A., Pérez-Pastén-Borja, R., Rivera-Yañez, N., & Ruiz-Hurtado, P. A. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101294 · Cited by 3

Innovative Approaches in Molecular Docking for the Discovery of Novel Inhibitors Against Alzheimer's Disease

Singh, B., Singh, K., Gupta, J. K., Semwal, B. C., Jain, D., & Sharma, M. C. (2025) · Current Alzheimer Research · doi:10.2174/0115672050386924250930184405 · Cited by 3

Plant-Derived Antioxidants for Management of COVID-19: A Comprehensive Review of Molecular Mechanisms.

Mokhtari, T., Azizi, M., Sheikhbahaei, F., Sharifi, H., & Sadr, M. (2023) · PubMed Central · Cited by 3

Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease

Jabeen, J., Ahmed, N., Shahzad, Z., Shahid, M., & Ahmad, T. (2024) · Future Pharmacology · doi:10.3390/futurepharmacol4030029 · Cited by 4

Nanomaterial Applications in Prevention and Treatment Strategies of Virus: A Review

Xin, G.-L., Zhang, C., Ni, J.-L., Li, Y., Sun, Y., & He, X. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00170 · Cited by 2

Nutraceuticals in prevention and management of COVID-19

Djuricic, I. D., Zrnić-Ćirić, M., Vidović, B. B., Todorović, V., Dabetić, N., & Ivanović, N. (2021) · Hrana i ishrana · doi:10.5937/hraish2102007d · Cited by 2

Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Estrada-Luna, D., Carreón‐Torres, E., González-Reyes, S., Martínez-Salazar, M. F., Ortiz-Rodríguez, M. A., Ramírez‐Moreno, E., Arias‐Rico, J., & Jiménez‐Osorio, A. S. (2022) · Life · doi:10.3390/life12101652 · Cited by 2

NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial

Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A., Monseur, J. J., & Henrotin, Y. E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1137407 · Cited by 2

The impact of emerging phytosome technology in healthcare management

Das, K. (2021) · Journal of Phytonanotechnology and Pharmaceutical Sciences · doi:10.21276/jpps.2021.1.2.4 · Cited by 2

Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses

Громова, О. А., Torshin, I. Y., & Chuchalin, A. G. (2023) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2023.162 · Cited by 1

Network Pharmacology and Experimental Validation of Qingwen Baidu Decoction Therapeutic Potential in COVID-19-related Lung Injury

Yang, J., Zhang, Z., Liu, H., Wang, J., Xie, S., Li, P., Wen, J., Wei, S., Li, R., Ma, X., et al. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073236899230919062725 · Cited by 1

Therapeutic potential of quercetin and its derivatives against COVID-19

Ab, K. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512505144 · Cited by 1

Flavonoid compound from Forsythia suspensa leaves inhibits adenovirus infection related to cell cycle based on UHPLC-Q-Exactive-Orbitrap/MS and experimental validation

Wang, L., Ren, S., Ma, X., Li, Y., Zheng, Y., Li, L., & Cao, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1627863 · Cited by 1

Nanocarriers for lung health: ameliorating inflammation and cell aging using flavonoid-based nano nutrients

Prasher, P., Sharma, M., Fatima, R., Vishwas, S., Singh, S., Chakraborty, A., Gupta, G., Chellappan, D. K., Dureja, H., Oliver, B. G. G., et al. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2625042 · Cited by 1

Structure-activity relationships and molecular mechanisms of natural products in sepsis-associated organ dysfunction: a narrative review

Wang, J., Cai, X., & Liang, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1808772 · Cited by 1

A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home

Farolfi, F., Cavazza, S., Mangiagalli, A., & Cavanna, L. (2022) · Cureus · doi:10.7759/cureus.30653 · Cited by 1

HIF-1a in immune pathogenesis of SARS-CoV-2-pneumonia

Volchkova, E. V., Кузубова, Н. А., Аleksаndrovich, Y. S., & Lebedeva, E. S. (2022) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology202205171 · Cited by 1

Bioinformatic and systems biology approach revealing the shared genes and molecular mechanisms between COVID-19 and non-alcoholic hepatitis

Lu, H., Ma, J., Li, Y., Zhang, J., An, Y., Du, W., & Cai, X.-F. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1164220 · Cited by 1

Safety assessment of the use of phytochemicals during in vitro, in vivo experiments and animal husbandry (review)

Kurilkina, M. Y., Rakhmatullin, S. G., Klimova, T. A., Deryabin, D. G., & Levakhin, G. I. (2023) · Животноводство и кормопроизводство · doi:10.33284/2658-3135-106-3-92 · Cited by 1

Therapeutic and prophylactic effects of quercetin in the treatment of Covid-19: a systematic review

Silva, G. D. O., Borba, E. F. D. O., Leão, A. D., Carneiro‐da‐Cunha, M. G., Maciel, M. A. M., Soares‐Sobrinho, J. L., Correia, M. T. D. S., & da Silva, T. G. (2024) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv22n1-192 · Cited by 2

Different Therapeutic Modalities for management of COVID-19

elmenshawy, S. M., Abdelsalam, M. H., Elnagdy, T., Elgohary, M. A., Sabri, N. A., & Elkhouly, A. (2024) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2024.252694.1150 · Cited by 1

Prospects of nanophytosomes in nanomedicine

Pal, S., Sharma, D., Pattni, B. S., & Yadav, N. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-819979-4.00007-6 · Cited by 2

Orthomolecular Therapy for Management & Prevention of SARS-CoV-2 Disease

Oyesaga, O. O. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24may1290 · Cited by 1

Quercetin Phospholipids Supplementation as a Natural Relief in Osteomuscular Health

Azienda Unità Sanitaria Locale (USL) Toscana Centro, 5. F., Miniati, I., Davolio, P. L., Farmad Laboratori Firenze Srl, F., Busi, S., Farmad Laboratori Firenze Srl, F., Petrangolini, G., Galluccio, F., & Fisiotech Lab Studio, R. A. P. M. (2024) · Physical Medicine and Rehabilitation - International · doi:10.26420/physmedrehabilint.2024.1245 · Cited by 1

Effectiveness of Herbal Medicine Add-on Treatments for COVID-19: An Updated Systematic Review and Meta-analysis of Clinical Trials

Kouhanjani, M. F., Keshavarzian, O., Kazemian, A., Heydarirad, G., Ameli, V., & Pasalar, M. (2025) · Shiraz E-Medical Journal · doi:10.5812/semj-158430 · Cited by 1

Phytochemicals in the Transmission Control of Epidemic Viruses: A Review Focused on SARS-CoV-2, Zika, and Dengue

Pamela, R.-H., Thompson-Bonilla, M. D. R., Casique‐Aguirre, D., Vázquez-Meraz, J. E., Jiménez‐Hernández, E., Mejía‐Aranguré, J. M., de la Torre, S. M.-D., Rangel-López, A., Xicohtencatl‐Cortés, J., Ochoa, S. A., et al. (2025) · Natural Product Communications · doi:10.1177/1934578x251333232 · Cited by 2

Outcome of Critically Ill COVID-19 Patients According to the Setting of Corticosteroid Initiation—A Retrospective Observational Cohort Study

Voicu, S., Lacoste-Palasset, T., Malissin, I., Bekhit, S., Cauchois, E., Dahmani, S., Saib, M., Grant, C., Naïm, G., M’Rad, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121359 · Cited by 1

Neglected Effective Early Therapies against COVID-19: Focus on Functional Foods and Related Active Substances. A ReviewPreprint

Donzelli, A. (2023) · Preprints.org · doi:10.20944/preprints202312.1178.v1

Mast Cells and their Role in Health and Disease

Faustino, A., & Oliveira, P. A. (2022) · Nova Science Publishers eBooks · doi:10.52305/gpjw5150

Use of dietary supplements and OTC products in the era of COVID-19

Tanzi, M. G. (2022) · Pharmacy Today · doi:10.1016/j.ptdy.2022.02.024

Are Antiviral Flavonoids Part of the Solution to the COVID-19 Pandemic?

Pizzorno, J. E. (2021) · PubMed Central

Peer Review #2 of "Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches (v0.2)"

(2022) · PeerJ · doi:10.7287/peerj.13374v0.2/reviews/2

Peer Review #1 of "Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches (v0.2)"

(2022) · PeerJ · doi:10.7287/peerj.13374v0.2/reviews/1

Peer Review #1 of "Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches (v0.1)"

(2022) · PeerJ · doi:10.7287/peerj.13374v0.1/reviews/1

Peer Review #2 of "Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches (v0.1)"

(2022) · PeerJ · doi:10.7287/peerj.13374v0.1/reviews/2

A wuhani és delta vírusvariánsok által okozott Covid-19 terápiájában alkalmazott természetes anyagok és gyógynövények a klinikai vizsgálatok tükrében

Csupor, D. (2022) · Lege Artis Medicinae · doi:10.33616/lam.32.022

Estudo in silico de fitoquímicos na região Receptor-Binding Domain (RBD) da proteína spike do SARS-CoV-2 (variante Ômicron, B.1.1.529)

Braz, H. L. B., de Souza, F. M., Soares, J. J. F., Alves, R. D. S., Jorge, R. J. B., & Cerqueira, G. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i10.33126

Pengaruh Penggunaan Terapi Adjuvant Terhadap Kesembuhan Pasien Covid 19 : Studi Literature

Sutrisna, M. (2022) · INSOLOGI Jurnal Sains dan Teknologi · doi:10.55123/insologi.v1i3.326

Supplementation with Vitamin D, Zinc, and Quercetin to Treat COVID-19: A Case ReportPreprint

Martin, B. (2023) · Qeios · doi:10.32388/pvzzlp

Targeting COVID-19 (SARS-CoV-2) main protease through phytochemicals of Albizia lebbeck: molecular docking, molecular dynamics simulation, MM–PBSA free energy calculations, and DFT analysis

Nalban, N., Wanjari, M., Kolhe, R., Tamboli, M., & Jamadagni, P. S. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00136-w

Polyphenols in Control of COVID ‐19

Berdimurodov, E. T., Berdimuradov, K., Kumar, A., Dagdag, O., Rbaa, M., & Jain, B. (2024) · doi:10.1002/9781394203932.ch13

TRP channels: Emerging targets in COVID-19 and its complications

Jaffal, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18653-0.00012-5

Mechanism and significance of cell senescence induced by viral infection

Chang, Y., Wu, X., Deng, L., Wang, S., & Mao, G. (2025) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0213 · Cited by 1

Flavonoids as Complementary Medicines for Therapy and Prevention of COVID-19: Part I. Experimental and Clinical Applications

Zverev, Y. F., & Rykunova, A. Y. (2024) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683824700194

Natural Substances in the Management of Coronavirus Disease 2019 Infection

Lucius, K. (2025) · Integrative and Complementary Therapies · doi:10.1089/ict.2025.70716.kl

Additional file 1 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Fang, J.-Y., Huang, K.-Y., Wang, T.-H., Lin, Z.-C., Chen, C.-C., Chang, S.-Y., Chen, E.-L., Chao, T.-L., Yang, S.-C., Yang, P.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25596372

Additional file 3 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Fang, J.-Y., Huang, K.-Y., Wang, T.-H., Lin, Z.-C., Chen, C.-C., Chang, S.-Y., Chen, E.-L., Chao, T.-L., Yang, S.-C., Yang, P.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26705682

Additional file 2 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Fang, J.-Y., Huang, K.-Y., Wang, T.-H., Lin, Z.-C., Chen, C.-C., Chang, S.-Y., Chen, E.-L., Chao, T.-L., Yang, S.-C., Yang, P.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25596546

Additional file 4 of Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Fang, J.-Y., Huang, K.-Y., Wang, T.-H., Lin, Z.-C., Chen, C.-C., Chang, S.-Y., Chen, E.-L., Chao, T.-L., Yang, S.-C., Yang, P.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26705685

Exploring phytomedicine in space medicine: Addressing health challenges in microgravity

Alum, E. U. (2026) · Life Sciences in Space Research · doi:10.1016/j.lssr.2026.01.005 · Cited by 1

Research progress of quercetin in infection at the maternal-fetal interface

Shi, J., Zhang, J., Gong, W., & Shen, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1851268

Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives

Lv, F., Chen, Y., & Xia, Y. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579010

Phytochemical-based approaches for next-generation anti-influenza a therapy amid rising drugs resistance

Mei, F. S., Ee, S. L. S., Subbiah, S. K., Thangavel, M., Anbalagan, M., Chinnappan, S., & Mani, R. R. (2026) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2026.09.008

Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Pierro, F. D., Khan, A. P., Iqtadar, S., Mumtaz, S. U., Chaudhry, M. N. A., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., Riva, A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1096853 · Cited by 63

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Di Pierro, F., Iqtadar, S., Khan, A., Ullah Mumtaz, S., Masud Chaudhry, M., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., Riva, A., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318949 · Cited by 180

Promising Effects of 3-Month Period of Quercetin Phytosome® Supplementation in the Prevention of Symptomatic COVID-19 Disease in Healthcare Workers: A Pilot Study

Rondanelli, M., Perna, S., Gasparri, C., Petrangolini, G., Allegrini, P., Cavioni, A., Faliva, M. A., Mansueto, F., Patelli, Z., Peroni, G., et al. (2022) · Life · doi:10.3390/life12010066 · Cited by 47

The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial

Ujjan, I. D., Khan, S., Nigar, R., Ahmed, H., Ahmad, S., & Khan, A. P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1023997 · Cited by 29

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Khan, A. P., Iqtadar, S., Mumtaz, S. U., Heinrich, M., Pascual-Figal, D. A., Livingstone, S. J., & Abaidullah, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898062 · Cited by 58